From the lab to the leadership team, breakthrough science demands collaboration. To further our mission to eliminate cancer and related diseases, we partner with top-caliber institutions, companies and philanthropic organizations.
As an academic, teaching and research institution, Fred Hutch works with other institutions worldwide to develop lifesaving, leading-edge therapies. We’re also joining forces to share research and resources as we provide some of the highest-quality care in the world through our clinical care partner, Seattle Cancer Care Alliance.
We also collaborate with leading technology companies on game-changing data science projects. One such project uses novel patient-engagement tools that employ biosensors and mobile apps, artificial intelligence and computer vision applications in radiology. Another project uses natural-language processing tools to reduce the time it takes to annotate patient records.
In 1998, Fred Hutch joined with UW Medicine and Seattle Children’s to create Seattle Cancer Care Alliance, one of the leading cancer treatment centers in the United States. SCCA provides clinical care to patients in the care of physicians from the three partner organizations.
The first comprehensive cancer center in Uganda, the UCI-Fred Hutch Cancer Centre focuses on cutting-edge research, training and clinical care. Jointly built by Fred Hutch and the Uganda Cancer Institute with support from the U.S. Agency for International Development and the government of Uganda, the center features life sciences and biomedical laboratories, training facilities and a clinic that can accommodate 16,000 outpatient visits each year.
Seattle Translational Tumor Research is a multidisciplinary effort involving physicians and scientists from Fred Hutch, UW Medicine and SCCA. Its primary goal: to translate laboratory sciences into the most precise, personalized treatment options for patients with solid-tumor cancers, including cancers of the brain, breast, colon, lung and prostate.
This UW Medicine, Fred Hutch and Seattle Children’s collaboration uses genetic or molecular profiling to create precision treatments for patients.
We work with the Allen Institute to chart the immune system using big data and emerging technologies to reveal how immunity goes astray in cancer.